InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by ROYSTON IVOR, Chairman & CEO. Officer active across 2 companies, notably Viracta Therapeutics, Inc.. Cumulatively, 8 reports have been logged. Total volume traded: €78k. The latest transaction was disclosed on 25 May 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
025,219 shares0
Common Stock
SEC:0001209191-22-032673:0·
025,219 shares0
Common Stock
SEC:0001209191-22-014442:0·
€5,5687,000 shares@ €0.795412.5% of flow
Common Stock
SEC:0001209191-21-071641·
€5,5687,000 shares@ €0.795412.5% of flow
Common Stock
SEC:0001209191-21-071641:0·
050,437 shares0
Common Stock
SEC:0001209191-21-067044·
050,437 shares0
Common Stock
SEC:0001209191-21-067044:0·
€38,8768,000 shares@ €4.859487.5% of flow
Common Stock
SEC:0001209191-21-064540·
Ideal exit: 12 Aug 2022 (T+270)
€38,8768,000 shares@ €4.859487.5% of flow
Common Stock
SEC:0001209191-21-064540:0·
Ideal exit: 12 Aug 2022 (T+270)
8 of 8 declarations
About ROYSTON IVOR
Ivor Royston is the Chief Executive Officer of Viracta Therapeutics, Inc. He leads the company focused on developing innovative therapies for cancer treatment. His role is crucial in guiding research and the development of new treatments.
